Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis
Siddharth Singh, Joseph D. Feuerstein, David G. Binion, et al.
Gastroenterology (2018) Vol. 156, Iss. 3, pp. 769-808.e29
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
Joseph D. Feuerstein, Kim L. Isaacs, Yecheskel Schneider, et al.
Gastroenterology (2020) Vol. 158, Iss. 5, pp. 1450-1461
Open Access | Times Cited: 556
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
Cynthia W. Ko, Siddharth Singh, Joseph D. Feuerstein, et al.
Gastroenterology (2018) Vol. 156, Iss. 3, pp. 748-764
Open Access | Times Cited: 259
Oral Metal‐Free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD)
Qiong Huang, Yuqi Yang, Yan Zhu, et al.
Small (2023) Vol. 19, Iss. 19
Closed Access | Times Cited: 80
AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis
Siddharth Singh, Jessica R. Allegretti, Shazia M. Siddique, et al.
Gastroenterology (2020) Vol. 158, Iss. 5, pp. 1465-1496.e17
Open Access | Times Cited: 135
New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance
Kartikeya Tripathi, Joseph D. Feuerstein
Drugs in Context (2019) Vol. 8, pp. 1-11
Open Access | Times Cited: 127
5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism
Ling Huang, Junping Zheng, Guangjun Sun, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Closed Access | Times Cited: 70
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Francesca Ferretti, Rosanna Cannatelli, Maria Camilla Monico, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2302-2302
Open Access | Times Cited: 69
Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
Eriko Yasutomi, Toshihiro Inokuchi, Sakiko Hiraoka, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 67
Natural-derived alkaloids exhibit great potential in the treatment of ulcerative colitis
Cailan Li, Jiahao Wang, Runfang Ma, et al.
Pharmacological Research (2021) Vol. 175, pp. 105972-105972
Closed Access | Times Cited: 57
Adverse health effects of emerging contaminants on inflammatory bowel disease
Xuejie Chen, Sidan Wang, Xueyi Mao, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 32
The ERK-cPLA2-ACSL4 axis mediating M2 macrophages ferroptosis impedes mucosal healing in ulcerative colitis
Yulin Ye, Limin Liu, Zelin Feng, et al.
Free Radical Biology and Medicine (2024) Vol. 214, pp. 219-235
Closed Access | Times Cited: 15
Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating iron
Yi Ru, Ying‐Li Luo, Didi Liu, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112318-112318
Closed Access | Times Cited: 10
Positioning Therapies in Ulcerative Colitis
Silvio Danese, Gionata Fiorino, Laurent Peyrin‐Biroulet
Clinical Gastroenterology and Hepatology (2020) Vol. 18, Iss. 6, pp. 1280-1290.e1
Closed Access | Times Cited: 70
A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease
Shanshan Li, Aiqing Xie, Hui Li, et al.
Journal of Controlled Release (2019) Vol. 316, pp. 66-78
Closed Access | Times Cited: 69
Inflammatory Bowel Disease – Non-biological treatment
Fernando Magro, Gonçalo Cordeiro, Andréia Dias, et al.
Pharmacological Research (2020) Vol. 160, pp. 105075-105075
Closed Access | Times Cited: 62
The Role of Autophagy in Inflammatory Bowel Disease
Bo‐Zong Shao, Yi Yao, Junshan Zhai, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 55
Multistage-Responsive Nanocomplexes Attenuate Ulcerative Colitis by Improving the Accumulation and Distribution of Oral Nucleic Acid Drugs in the Colon
Xiaoxin Li, Yanyan Yang, Zhibin Wang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 1, pp. 2058-2070
Closed Access | Times Cited: 38
Curcumin regulates the homeostasis of Th17/Treg and improves the composition of gut microbiota in type 2 diabetic mice with colitis
Qiuping Xiao, Youbao Zhong, Zeng‐Ping Kang, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 4, pp. 1708-1723
Open Access | Times Cited: 30
Management and treatment optimization of patients with mild to moderate ulcerative colitis
Ferdinando D’Amico, Ernesto Fasulo, Vipul Jairath, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 277-290
Closed Access | Times Cited: 17
Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation
Jonathan Skupsky, Subrata Sabui, Ji Won Hwang, et al.
Cellular and Molecular Gastroenterology and Hepatology (2019) Vol. 9, Iss. 4, pp. 557-567
Open Access | Times Cited: 43
Ulcerative Colitis: Disease Burden, Impact on Daily Life, and Reluctance to Consult Medical Professionals: Results from a Japanese Internet Survey
Toshifumi Hibi∥, Toyomi Ishibashi, Yuka Ikenoue, et al.
Inflammatory Intestinal Diseases (2020) Vol. 5, Iss. 1, pp. 27-35
Open Access | Times Cited: 43
Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis
Brigida Barberio, Jonathan Segal, Mohammed Nabil Quraishi, et al.
Journal of Crohn s and Colitis (2021) Vol. 15, Iss. 7, pp. 1184-1196
Open Access | Times Cited: 37
Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis
Juntao Yin, Lunshou Wei, Naiqin Wang, et al.
Journal of Ethnopharmacology (2022) Vol. 289, pp. 115041-115041
Closed Access | Times Cited: 27
Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
Renato Sablich, Maria Teresa Urbano, Marco Scarpa, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Curcumin use in ulcerative colitis: is it ready for prime time? A systematic review and meta-analysis of clinical trials
Saurabh Chandan
Annals of Gastroenterology (2019)
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top